We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$16.9B
AUM Growth
+$10.5B
Cap. Flow
+$12.3B
Cap. Flow %
72.41%
Top 10 Hldgs %
24.17%
Holding
648
New
193
Increased
117
Reduced
69
Closed
177

Sector Composition

Rank Sector Weight
1 Healthcare 3.81%
2 Communication Services 3.67%
3 Financials 3.11%
4 Technology 3.1%
5 Consumer Discretionary 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STTK icon
351
Shattuck Labs
STTK
$682M
$1.37M 0.01%
506,000
TROW icon
352
T. Rowe Price
TROW
$24.4B
$1.36M 0.01%
+13,003
New +$1.55M
EW icon
353
CALL
Edwards Lifesciences
EW
$53.8B
$1.36M 0.01%
+16,500
New +$1.59M
MGM icon
354
PUT
MGM Resorts International
MGM
$11B
$1.34M 0.01%
+45,100
New +$1.47M
ACET icon
355
Adicet Bio
ACET
$76.3M
$1.29M 0.01%
5,678
-21,917
-79% -$5.56M
MTB icon
356
M&T Bank
MTB
$36.5B
$1.29M 0.01%
+7,306
New +$1.29M
DLTR icon
357
Dollar Tree
DLTR
$24.8B
$1.25M 0.01%
+9,187
New +$1.43M
VIGL
358
DELISTED
Vigil Neuroscience
VIGL
$1.19M 0.01%
130,200
OYST
359
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$1.18M 0.01%
210,200
YUMC icon
360
Yum China
YUMC
$16.2B
$1.15M 0.01%
24,261
-29,121
-55% -$1.4M
CRDF icon
361
Cardiff Oncology
CRDF
$80.1M
$1.11M 0.01%
722,100
ETNB
362
DELISTED
89bio
ETNB
$1.08M 0.01%
187,100
MLCO icon
363
PUT
Melco Resorts & Entertainment
MLCO
$2.13B
$1.06M 0.01%
+159,400
New +$879K
THRX
364
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.04M 0.01%
179,619
IHS icon
365
IHS Holding
IHS
$2.8B
$1.02M 0.01%
183,173
-25,074
-12% -$192K
PAYX icon
366
CALL
Paychex
PAYX
$42.8B
$1.01M 0.01%
+9,000
New +$1.12M
LITS
367
Lite Strategy Inc
LITS
$29.6M
$996K 0.01%
128,845
SQZ
368
DELISTED
SQZ Biotechnologies Company
SQZ
$984K 0.01%
431,400
NMTR
369
DELISTED
9 Meters Biopharma
NMTR
$980K 0.01%
227,910
+256
+0.1% +$1.27K
U icon
370
Unity
U
$18.7B
$956K 0.01%
+30,000
New +$1.23M
ISEE
371
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$949K 0.01%
52,871
+2,793
+6% +$36.7K
TSHA icon
372
Taysha Gene Therapies
TSHA
$1.83B
$854K 0.01%
442,600
LYFT icon
373
CALL
Lyft
LYFT
$6.58B
$847K 0.01%
+64,300
New +$989K
DNTH icon
374
Dianthus Therapeutics
DNTH
$6.19B
$821K ﹤0.01%
36,394
RWAY icon
375
Runway Growth Finance
RWAY
$279M
$806K ﹤0.01%
70,898
-5,150
-7% -$64.2K

Similar funds

Laurion Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Laurion Capital Management held 648 positions worth $16.9B, up 162% from $6.47B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Laurion Capital Management deployed $12.3B of net new capital in Q3 2022, opening 193 new positions and adding to 117 existing holdings. Its largest new stake was Adobe: 254,770 shares worth $70.1M.

By sector, the portfolio is most concentrated in Healthcare at 3.8% of assets, down from 12% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $165M trimmed.

  • Laurion Capital Management's largest Q3 2022 buy was Adobe: 254,770 shares worth $70.1M.
  • Laurion Capital Management added most to Alphabet (Google) Class A in Q3 2022, an estimated $215M increase.
  • Laurion Capital Management's biggest Q3 2022 reduction was Lowe's Companies, cutting an estimated $165M.
  • Laurion Capital Management fully exited Warner Bros in Q3 2022, selling an estimated $213M.
  • Laurion Capital Management's ten largest holdings make up 24% of its $16.9B portfolio in Q3 2022.
  • Laurion Capital Management opened 193 new positions and closed 177 in Q3 2022.
  • Laurion Capital Management's portfolio value rose 162% quarter-over-quarter to $16.9B.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.